The Valley Desk

ArticleJournal of comparative effectiveness researchPublished

A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Johnson & Johnson, Perelman School of Medicine, with Penn Medicine, University of Pennsylvania linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Journal of comparative effectiveness research
Published
Subject terms
Humans; Benzamides; Piperidines; Pyrazines; Adenine; Antineoplastic Agents; Protein Kinase Inhibitors; Databases, Factual; Aged; Aged, 80 and over; Middle Aged; Health Care Costs
PubMed ID
40261261
PubMed Central ID
PMC12142381
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal